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Abstract: 
Background: The damaging consequences that diabetes mellitus holds for the body are widely understood. Less focus, however, 
has been allotted to the consequences it holds for the mind. Diabetes mellitus, especially type-I, has been linked to a 
compromised performance on various cognitive function domains. The precise pathophysiological route of cognitive dysfunction 
among diabetics is not fully understandable, but it is probable that modalities that bring about effects on the body, too are 
responsible for affecting the mind.  
Objective: To study the effects that diabetes, a physically belittling disease, has on the mind and its ability to function by looking 
for clinically relevant cognitive impairment in individuals suffering from the disease. 
 Methods: This observational, cross-sectional study included a sample of 200 individuals suffering from diabetes mellitus aged 
60 and above, selected using consecutive sampling, and presenting at the medicine unit 2 outpatient department at Liaquat 
University Hospital. Jamshoro and Hyderabad from January 1, 2016 to April 10, 2016. Verbal informed consent was obtained 
before administering structured interview administered questionnaires. Cognitive decline was assessed using the Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE) and a supplementary self-structured questionnaire for qualitative 
insight into the cognitive state and its correlates. 
Result: The presence of clinically relevant cognitive impairment was two times higher among participants with type 1 than type 2 
diabetes Mellitus. Both types of diabetes showed statistically significant difference than the normal values of the population. 
Conclusion: Clinically relevant cognitive impairment is highly prevalent among subjects with childhood-onset type I diabetes 
mellitus. Chronic hyperglycemia and hypoglycemia are thought to be the causes behind this cognitive impairment.  
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The damage that diabetes mellitus inflicts on the 
renal, retinal, peripheral nervous system and 
cardiovascular system are well known. Less focus, 
however, has been allotted to the consequences it 
holds for the mind. Diabetes mellitus, especially 
type-I, has been linked to a compromised 
performance on various cognitive function domains. 
The precise pathophysiological route of cognitive 
dysfunction among diabetics is not fully 
understandable, but it is probable that hyperglycemia, 
hypoglycemia play decisive roles.  
Looking deeper, diabetes mellitus is an intricate 
metabolic ailment that can have distressing 
consequences for many bodily organs. This giant of a 
disease is the prime reason, in the United States, 
leading to end stage renal disease [1]. In addition to 
the aforementioned, diabetes is also a commonly 
leads to loss of vision, neuropathy, and diseases of 
cardiovascular origin. A seemingly less attended and 
poorly recognized consequence of diabetes is 
cognitive dysfunction. Type 1 and type 2 diabetes 
mellitus patients have been diagnosed with clinically 
relevant cognitive deficiencies that can be linked to 
the two types of diabetes. Both hyperglycemia and 
hypoglycemia have been associated with cognitive 
dysfunction, and the fear that recurrent hypoglycemia 
will weaken their memory with time, is prevalent 
among the patients. Though extensive research has 
been conducted, the underlying pathophysiology of 
this adverse consequence is not well understood, and 
the best diagnostic methods, treatment options, and 
prevention strategies for cognitive dysfunction in 
diabetes have not yet surfaced.  
It cannot be said enough that though extensive 
research has been done and much insight has been 
gained regarding cognitive dysfunction in patients 
with diabetes, more is still needed, particularly 
regarding the natural history and mechanisms of this 
consequence in an attempt to to develop strategies for 
treatment and prevention. Here in this article we use 
memory as an indicator of cognitive ability and use it 
to draw inferences regarding the overall cognitive 
health of the subjects. 
METHODOLOGY: 
This observational, cross-sectional study included a 
sample of 200 individuals suffering from diabetes 
mellitus aged 60 and above, selected using 
consecutive sampling, and presenting at the medicine 
unit 2 outpatient departments at Liaquat University 
Hospital. Jamshoro and Hyderabad from January 1, 
2016 to April 10, 2016. Verbal informed consent was 
obtained before administering structured interview 
administered questionnaires. Cognitive decline was 
assessed using the Informant Questionnaire on 
Cognitive Decline in the Elderly (IQCODE) and a 
supplementary self-structured questionnaire for 
qualitative insight into the cognitive state and its 
correlates.  
RESULTS: 
The prevalence of clinically relevant cognitive 
impairment was two times greater among subjects 
with type 1 than type 2 diabetes Mellitus. Both types 
of diabetes showed statistically significant difference 
than the normal values of the population. The sample 
was divided between the two types of diabetes as 
shown below. 
 
Fig 1: The frequency was not kept intentionally equal, and it was only a matter of coincidence that the 
numbers turned out to be equal. The ratio equality came as a surprise since the prevalence of the two types is 
not similar in the study setting neither in most parts of the globe. Collection of sample over a larger time 
period might have yielded different results. 
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The individuals suffering from diabetes type 2, as stated above, fared well in the wide test poised by the Informant 
Questionnaire on Cognitive Decline in the Elderly (IQCODE). In fact they fare 2 times better than the individuals 
suffering from diabetes type 2. 
 
Fig 2: The difference indicates that diabetes type 1 is more mentally debilitating than diabetes type 2. The 
reasons however, of such a difference did not surface in the research. 
Both types of diabetes showed statistically significant difference than the normal values of the population. The 
normal values were not however, derived from control subjects but the IQCODE database that gives values for 
normal individuals throughout the globe. An average was taken as the normal mean result (per item). 
 
Fig 3: The p value obtained was lower than 0.05. Thus, validating the hypothesis by a less than 5% margin of 
error and a greater than 95% confidence interval. 
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DISCUSSION: 
The pathophysiology that underlies the advent of 
cognitive dysfunction in diabetic patients has not 
been fully explained. Numerous hypotheses exist, 
that too with supporting evidence, including probable 
causative function of hyperglycemia, hypoglycemia, 
vascular disease, amyloid deposition and insulin 
resistance. Even though further research into each of 
these probable pathways is crucial, it may be very 
well turn out that ultimate cause might not be single 
but an amalgam of all these factors, depending on the 
patient’s type of diabetes, age, comorbidities and type 
of therapy. 
 
Hyperglycemia seems to be linked with abnormalities 
in cognitive function among type 1 and type 2 
diabetes patients. Yet, the pathways via which 
hyperglycemia may bring about this consequence are 
not completely clear. In organs other than the brain, 
hyperglycemia affects function via a multitude of 
pathways including hiked synthesis of advanced 
glycation end products (AGEs), polyol pathway 
activation, hiked glucose shunting in the hexosamine 
pathway, diacylglycerol activation of protein kinase 
C [2-5]. The similar pathways might be functioning 
in the brain and bringing about the alterations in 
cognitive function that have been seen in diabetic 
patients. 
 
Compromised function of the neurotransmitter has 
also been seen in diabetic models and might add to 
further aggravate the cognitive dysfunction [6]. Other 
changes in the neurochemicals too have been seen, 
including lessened acetylcholine [7], lower turnover 
of serotonin, hampered activity of dopamine, and 
hiked norepinephrine [8, 9] in the brains of diabetic 
animals plagued. Fascinatingly such alterations were 
all put to an end with insulin. A fresh hypothesis 
proposes that the changing low and high levels of 
glucose observed in patients with poorly controlled 
diabetes may worsen function of neurotransmitters 
[9]. 
 
Whether or not repeated hypoglycemic episodes 
aggravate cognitive dysfunction is controversial and 
is most probably dependent on the patients’ age. Yet, 
it is clear that severe hypoglycemia if lasting for an 
extended period of time, shall cause brain damage 
and even death [11-14]. Autopsy studies in humans 
done in individuals who died due to hypoglycemia 
have exhibited diffuse or multifocal necrosis in the 
cerebral cortex and ganglion cell chromatolysis [15-
17].  
 
 
 
CONCLUSION: 
Clinically relevant cognitive impairment is highly 
prevalent among subjects with childhood-onset type I 
diabetes mellitus. Chronic hyperglycemia and 
hypoglycemia are thought to be the causes behind 
this cognitive impairment.  
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